Bone metastases from prostate cancer are detected with staging bone scans. New research supports existing guidelines on the appropriate referral criteria for bone scans and shows that a specific subgroup of patients with prostate cancer who are at low risk of bone metastases do not require a staging bone scan.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mohler, J. et al. NCCN clinical practice guidelines in oncology: prostate cancer. J. Natl Compr. Canc. Netw. 8, 162–200 (2010).
McArthur, C., McLaughlin, G. & Meddings, R. N. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients. Br. J. Radiol. doi:10.1259/bjr/79184355.
3. Lecouvet, F. E. et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J. Clin. Oncol. 25, 3281–3287 (2007).
Smith, M. R., Cook, R., Lee, K. A. & Nelson, J. B. Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer. Cancer doi:10.1002/cncr.25762.
Smith, M. R. et al. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J. Clin. Oncol. 23, 2918–2925 (2005).
Coleman, R. et al. Consensus on the utility of bone markers in the malignant bone disease setting. Crit. Rev. Oncol. Hematol. doi:10.1016/j.critrevonc.2011.02.005.
Saad, F., Eastham, J. A. & Smith, M. R. Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer. Urol. Oncol. doi:10.1016/j.urolonc.2010.08.007.
Saad, F. & Eastham, J. Zoledronic acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. Urology 76, 1175–1181 (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Saad, F. Searching for bone metastases—how, when and why?. Nat Rev Urol 8, 358–359 (2011). https://doi.org/10.1038/nrurol.2011.70
Published:
Issue date:
DOI: https://doi.org/10.1038/nrurol.2011.70